New thrombolytic, Retavase (reteplase)
January 1997
Boehringer Mannheim will soon market a new thrombolytic, Retavase (reteplase)...to dissolve blood clots and restore blood flow after a heart attack.
Retavase is a derivative of tissue plasminogen activator (tPA)...the protein in Activase (alteplase).
Retavase restores blood flow in more patients after 90 minutes than Activase. But so far there's no evidence of improved survival over Activase or streptokinase.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote